jane larkindale - why are c-path drug development tools important in rare disease drug development?
Published 4 years ago • 29 plays • Length 2:27Download video MP4
Download video MP3
Similar videos
-
1:59
jane larkindale - what is c-path doing that is unique in drug development for rare disease?
-
0:37
diane stephenson - why is c-path so important in the drug development space?
-
11:08
rare disease endpoint advancement rdea pilot program
-
4:12
why are high-quality standardized databases so critical for drug development?
-
29:30
accelerating drug development for rare diseases through data sharing and analysis
-
3:33
4 signs of addictive behavior from our expert
-
5:27
what is the critical path method (cpm)?
-
10:38
data analytics case study | medical research for eating disorders | abhishek agarrwal
-
8:03
rdca-dap: how the data and analytics platform accelerates rare disease drug development
-
1:42
jane larkindale - how can data sharing reduce the cost of clinical trials?
-
57:07
what you need to know about the rare disease cures accelerator-data and analytics platform
-
5:18
what is exciting to you about taking on this ambitious project?
-
45:31
derisking rare disease drug development and measuring impact and outcomes with andrew lo
-
46:37
clinical trial simulation tools advancing treatments in rare disease
-
0:43
steve broadbent - why is c-path so important in the regulatory science area?
-
3:27
what does the fda hope to achieve through developing the rare disease cures accelerator?
-
1:24:07
regulatory pathway and applications in drug development for rare diseases
-
2:16
klaus romero - what does c-path do?
-
2:26
how does trxa help bridge the drug development "valley of death?"
-
1:36:06
webinar: rdca-dap and eatris present rare disease drug development
-
29:30
accelerating drug development for rare diseases through data sharing and analysis
-
3:48
how has the presence or lack of data changed drug development for platelet disorders?